KIT(D816V) Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
KIT(D816V) Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma. / Phung, Bengt; Kazi, Julhash U; Lundby, Alicia; Bergsteinsdottir, Kristin; Sun, Jianmin; Goding, Colin R; Jönsson, Göran; Olsen, Jesper V; Steingrímsson, Eiríkur; Rönnstrand, Lars.
In: Molecular cancer research : MCR, Vol. 15, No. 9, 2017, p. 1265-1274.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - KIT(D816V) Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma
AU - Phung, Bengt
AU - Kazi, Julhash U
AU - Lundby, Alicia
AU - Bergsteinsdottir, Kristin
AU - Sun, Jianmin
AU - Goding, Colin R
AU - Jönsson, Göran
AU - Olsen, Jesper V
AU - Steingrímsson, Eiríkur
AU - Rönnstrand, Lars
N1 - ©2017 American Association for Cancer Research.
PY - 2017
Y1 - 2017
N2 - The oncogenic D816V mutation of the KIT receptor is well characterized in systemic mastocytosis and acute myeloid leukemia. Although KIT(D816V) has been found in melanoma, its function and involvement in this malignancy is not understood. Here we show that KIT(D816V) induces tyrosine phosphorylation of MITF through a triple protein complex formation between KIT, MITF, and SRC family kinases. In turn, phosphorylated MITF activates target genes that are involved in melanoma proliferation, cell-cycle progression, suppression of senescence, survival, and invasion. By blocking the triple protein complex formation, thus preventing MITF phosphorylation, the cells became hypersensitive to SRC inhibitors. We have therefore delineated a mechanism behind the oncogenic effects of KIT(D816V) in melanoma and provided a rationale for the heightened SRC inhibitor sensitivity in KIT(D816V) transformed cells.Implications: This study demonstrates that an oncogenic tyrosine kinase mutant, KIT(D816V), can alter the transcriptional program of the transcription factor MITF in melanoma Mol Cancer Res; 15(9); 1265-74. ©2017 AACR.
AB - The oncogenic D816V mutation of the KIT receptor is well characterized in systemic mastocytosis and acute myeloid leukemia. Although KIT(D816V) has been found in melanoma, its function and involvement in this malignancy is not understood. Here we show that KIT(D816V) induces tyrosine phosphorylation of MITF through a triple protein complex formation between KIT, MITF, and SRC family kinases. In turn, phosphorylated MITF activates target genes that are involved in melanoma proliferation, cell-cycle progression, suppression of senescence, survival, and invasion. By blocking the triple protein complex formation, thus preventing MITF phosphorylation, the cells became hypersensitive to SRC inhibitors. We have therefore delineated a mechanism behind the oncogenic effects of KIT(D816V) in melanoma and provided a rationale for the heightened SRC inhibitor sensitivity in KIT(D816V) transformed cells.Implications: This study demonstrates that an oncogenic tyrosine kinase mutant, KIT(D816V), can alter the transcriptional program of the transcription factor MITF in melanoma Mol Cancer Res; 15(9); 1265-74. ©2017 AACR.
U2 - 10.1158/1541-7786.MCR-17-0149
DO - 10.1158/1541-7786.MCR-17-0149
M3 - Journal article
C2 - 28584020
VL - 15
SP - 1265
EP - 1274
JO - Molecular Cancer Research
JF - Molecular Cancer Research
SN - 1541-7786
IS - 9
ER -
ID: 184291130